This report contains market size and forecasts of Low-density Lipoprotein Apheresis Therapy in Global, including the following market information:
Global Low-density Lipoprotein Apheresis Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Low-density Lipoprotein Apheresis Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Double Filtration LDL Apheresis Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Low-density Lipoprotein Apheresis Therapy include Kaneka Pharma, B.Braun, Fresenius Medical Care, Asahi Kasei Medical, Medicap, Kawasumi Laboratories, Terumo Corporation and Haemonetics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Low-density Lipoprotein Apheresis Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Low-density Lipoprotein Apheresis Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Low-density Lipoprotein Apheresis Therapy Market Segment Percentages, by Type, 2021 (%)
Double Filtration LDL Apheresis Therapy
Cascade Filtration LDL Apheresis Therapy
Global Low-density Lipoprotein Apheresis Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Low-density Lipoprotein Apheresis Therapy Market Segment Percentages, by Application, 2021 (%)
Atherosclerosis Patient
Obesity Patient
Dyslipidemia Patient
Coronary Heart Disease Patient
Carotid Artery Disease Patient
Global Low-density Lipoprotein Apheresis Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Low-density Lipoprotein Apheresis Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Low-density Lipoprotein Apheresis Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Low-density Lipoprotein Apheresis Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Kaneka Pharma
B.Braun
Fresenius Medical Care
Asahi Kasei Medical
Medicap
Kawasumi Laboratories
Terumo Corporation
Haemonetics